Weilin Xie

Dr. Weilin Xie is Principal Senior Scientist at Celgene Corporation. He directed Celgene’s fibrosis research unit through 2016. As a project leader or biology lead, he and his team have advanced multiple fibrosis projects from early discovery to clinic or IND filings. As a member of Celgene’s due diligence teams, Dr. Xie has been instrumental in several high profile collaborations and acquisitions within Celgene’s fibrosis and inflammation/auto-immunity franchise. Additionally, as a member of Celgene’s Joint Research Committee, he oversees many corporate collaborations. Dr. Xie co-initiated Celgene’s protein homeostasis drug discovery efforts by targeting E2 and E3 ubiqutin ligases and was co-project leader for identifying the mechanism of action of Celgene’s IMiDs class drugs.